John D. Gordan
0000-0001-8997-5725
Publication & Citation Trends
Publications
0 total
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update Clinical Insights.
Cited by 10
Semantic Scholar
Human GM-CSF/IL-3 enhance tumor immune infiltration in humanized HCC patient-derived xenografts OA
Cited by 1
Semantic Scholar
Emerging Therapies for the Management of Human Epidermal Growth Factor Receptor 2-/ERBB2-Altered Advanced Biliary Tract Cancers.
Cited by 1
Semantic Scholar
Changes in alpha-fetoprotein across the systemic therapy continuum in advanced hepatocellular carcinoma—a real-world, multicenter study
Cited by 2
Semantic Scholar
HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma.
Cited by 3
Semantic Scholar
Recruitment of BAG2 to DNAJ-PKAc scaffolds promotes cell survival and resistance to drug-induced apoptosis in fibrolamellar carcinoma OA
Cited by 13
Semantic Scholar
New Opportunities to Individualize Frontline Therapy in Advanced Stages of Hepatocellular Carcinoma
Cited by 9
Semantic Scholar
Research Topics
Cholangiocarcinoma and Gallbladder Cancer Studies
(51)
Cancer Mechanisms and Therapy
(39)
Chromatin Remodeling and Cancer
(31)
Hepatocellular Carcinoma Treatment and Prognosis
(29)
Cancer Genomics and Diagnostics
(22)
Affiliations
QB3
Binghamton University
The University of Sydney
Memorial Sloan Kettering Cancer Center
Children's Hospital of Philadelphia